Macromolecular Crystallography Group, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), c/Melchor Fdez. Almagro 3, 28029 Madrid, Spain.
Cell Mol Life Sci. 2010 Mar;67(5):727-48. doi: 10.1007/s00018-009-0188-y.
Homing endonucleases (HE) are double-stranded DNAses that target large recognition sites (12-40 bp). HE-encoding sequences are usually embedded in either introns or inteins. Their recognition sites are extremely rare, with none or only a few of these sites present in a mammalian-sized genome. However, these enzymes, unlike standard restriction endonucleases, tolerate some sequence degeneracy within their recognition sequence. Several members of this enzyme family have been used as templates to engineer tools to cleave DNA sequences that differ from their original wild-type targets. These custom HEs can be used to stimulate double-strand break homologous recombination in cells, to induce the repair of defective genes with very low toxicity levels. The use of tailored HEs opens up new possibilities for gene therapy in patients with monogenic diseases that can be treated ex vivo. This review provides an overview of recent advances in this field.
归巢内切核酸酶(HE)是靶向较大识别位点(12-40bp)的双链 DNA 酶。HE 编码序列通常嵌入在内含子或内肽酶中。它们的识别位点极其罕见,在哺乳动物大小的基因组中没有或只有少数这些位点存在。然而,与标准限制内切核酸酶不同,这些酶在其识别序列中可以容忍一些序列简并性。这种酶家族的几个成员已被用作模板来设计工具,以切割与其原始野生型靶标不同的 DNA 序列。这些定制的 HE 可用于刺激细胞中的双链断裂同源重组,以诱导具有非常低毒性水平的缺陷基因修复。定制 HE 的使用为单基因疾病患者的基因治疗开辟了新的可能性,这些患者可以在体外进行治疗。本文综述了该领域的最新进展。